US Bancorp DE Trims Holdings in Teladoc Health, Inc. (NYSE:TDOC)

US Bancorp DE reduced its stake in Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 20.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 95,122 shares of the health services provider’s stock after selling 25,070 shares during the quarter. US Bancorp DE owned 0.06% of Teladoc Health worth $2,411,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in TDOC. Renaissance Technologies LLC boosted its position in shares of Teladoc Health by 879.2% during the second quarter. Renaissance Technologies LLC now owns 4,475,319 shares of the health services provider’s stock worth $148,625,000 after buying an additional 4,018,300 shares during the period. State of Michigan Retirement System acquired a new position in Teladoc Health in the 2nd quarter valued at about $123,089,000. Himension Capital Singapore PTE. LTD. increased its stake in Teladoc Health by 67.7% during the second quarter. Himension Capital Singapore PTE. LTD. now owns 2,167,552 shares of the health services provider’s stock worth $71,984,000 after purchasing an additional 875,344 shares during the period. Connor Clark & Lunn Investment Management Ltd. lifted its position in shares of Teladoc Health by 893.9% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 351,898 shares of the health services provider’s stock worth $11,687,000 after purchasing an additional 316,492 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Teladoc Health in the second quarter valued at approximately $6,065,000. Institutional investors and hedge funds own 84.14% of the company’s stock.

Insider Buying and Selling

In other Teladoc Health news, insider Arnnon Geshuri sold 2,398 shares of the stock in a transaction dated Monday, November 28th. The shares were sold at an average price of $27.35, for a total value of $65,585.30. Following the completion of the transaction, the insider now directly owns 74,317 shares of the company’s stock, valued at $2,032,569.95. The sale was disclosed in a filing with the SEC, which is available at this link. Over the last 90 days, insiders have sold 3,925 shares of company stock valued at $105,198. Corporate insiders own 1.55% of the company’s stock.

Analyst Ratings Changes

TDOC has been the topic of several recent research reports. Truist Financial cut their target price on shares of Teladoc Health from $35.00 to $29.00 and set a “hold” rating on the stock in a research note on Friday, October 21st. DA Davidson cut their price target on Teladoc Health from $45.00 to $40.00 and set a “buy” rating on the stock in a report on Tuesday, October 25th. StockNews.com raised Teladoc Health to a “sell” rating in a research report on Thursday, January 5th. Guggenheim raised shares of Teladoc Health from a “sell” rating to a “neutral” rating in a report on Monday, October 24th. Finally, Oppenheimer lowered their price target on shares of Teladoc Health from $55.00 to $45.00 in a report on Thursday, October 27th. One analyst has rated the stock with a sell rating, twenty-two have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Teladoc Health has an average rating of “Hold” and an average target price of $48.21.

Teladoc Health Stock Performance

Shares of NYSE:TDOC opened at $26.92 on Friday. Teladoc Health, Inc. has a 52 week low of $21.60 and a 52 week high of $82.99. The company has a 50-day moving average price of $26.70 and a 200 day moving average price of $30.55. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.99 and a current ratio of 3.13.

Teladoc Health (NYSE:TDOC – Get Rating) last announced its quarterly earnings data on Wednesday, October 26th. The health services provider reported ($0.45) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.59) by $0.14. Teladoc Health had a negative return on equity of 2.47% and a negative net margin of 424.40%. The firm had revenue of $611.40 million for the quarter, compared to analyst estimates of $609.45 million. As a group, research analysts predict that Teladoc Health, Inc. will post -1.4 EPS for the current fiscal year.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.